Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The combination of artesunate and mefloquine was introduced as the national first-line treatment for Plasmodium falciparum malaria in Cambodia in 2000. However, recent clinical trials performed at the Thai-Cambodian border have pointed to the declining efficacy of both artesunate-mefloquine and artemether-lumefantrine. Since pfmdr1 modulates susceptibility to mefloquine and artemisinin derivatives, the aim of this study was to assess the link between pfmdr1 copy number, in vitro susceptibility to individual drugs and treatment failure to combination therapy. METHODS: Blood samples were collected from P. falciparum-infected patients enrolled in two in vivo efficacy studies in north-western Cambodia: 135 patients were treated with artemether-lumefantrine (AL group) in Sampovloun in 2002 and 2003, and 140 patients with artesunate-mefloquine (AM group) in Sampovloun and Veal Veng in 2003 and 2004. At enrollment, the in vitro IC50 was tested and the strains were genotyped for pfmdr1 copy number by real-time PCR. RESULTS: The pfmdr1 copy number was analysed for 115 isolates in the AM group, and for 109 isolates in the AL group. Parasites with increased pfmdr1 copy number had significantly reduced in vitro susceptibility to mefloquine, lumefantrine and artesunate. There was no association between pfmdr1 polymorphisms and in vitro susceptibilities. In the patients treated with AM, the mean pfmdr1copy number was lower in subjects with adequate clinical and parasitological response compared to those who experienced late treatment failure (n = 112, p < 0.001). This was not observed in the patients treated with AL (n = 96, p = 0.364). The presence of three or more copies of pfmdr1 were associated with recrudescence in artesunate-mefloquine treated patients (hazard ratio (HR) = 7.80 [95%CI: 2.09-29.10], N = 115), p = 0.002) but not with recrudescence in artemether-lumefantrine treated patients (HR = 1.03 [95%CI: 0.24-4.44], N = 109, p = 0.969). CONCLUSION: This study shows that pfmdr1 copy number is a molecular marker of AM treatment failure in falciparum malaria on the Thai-Cambodian border. However, while it is associated with increased IC50 for lumefantrine, pfmdr1 copy number is not associated with AL treatment failure in the area, suggesting involvement of other molecular mechanisms in AL treatment failures in Cambodia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique
Desjardins, R. E., Canfield, C. J., Haynes, J. D., & Chulay, J. D. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.6.710 · Cited by 2,514 · cited 1×
“The in vitro drug sensitivity of the Cambodian isolates was assessed by use of a classical isotopic 48 h test [11].”
MethodMefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number
Price, R. N., Uhlemann, A.-C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16767-6 · Cited by 853
Bloland, P. B., Ringwald, P., & Snow, R. W. (2003) · Cited by 639
Self-citationChloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross
Wellems, T. E., Panton, L. J., Gluzman, I. Y., do Rosário, V. E., Gwadz, R. W., Walker-Jonah, A., & Krogstad, D. J. (1990) · Nature · doi:10.1038/345253a0 · Cited by 557
Snounou, G., Zhu, X., Siripoon, N., Jarra, W., Thaithong, S., Brown, K. N., & Viriyakosol, S. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90120-7 · Cited by 546 · cited 1×
“The number of variants in three polymorphic genes (msp1, msp2 and glurp) was determined as described previously [13,14].”
BackgroundPrice, R. N., Uhlemann, A.-C., van Vugt, M., Brockman, A., Hutagalung, R., Nair, S., Nash, D., Singhasivanon, P., Anderson, T. J. C., Krishna, S., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/503423 · Cited by 317 · cited 2×
“Interestingly, pfmdr1 copy number had apparently no impact on clinical AL failure even though it was associated with decreased in vitro susceptibility to both artemether and lumefantrine [19,22].”
BackgroundResultPrice, R. N., Cassar, C., Brockman, A., Duraisingh, M., van Vugt, M., White, N. J., Nosten, F., & Krishna, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2943 · Cited by 279 · cited 1×
“Increased pfmdr1 copy number was also associated with decreased in vitro susceptibility to mefloquine, lumefantrine and, to a lesser degree artesunate, which is consistent with previous studies [20-22].”
ResultResistance to Antimalarials in Southeast Asia and Genetic Polymorphisms in pfmdr1
Pickard, A. L., Wongsrichanalai, C., Purfield, A., Kamwendo, D., Emery, K., Zalewski, C., Kawamoto, F., Miller, R. S., & Meshnick, S. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2418-2423.2003 · Cited by 279 · cited 1×
“Increased pfmdr1 copy number was also associated with decreased in vitro susceptibility to mefloquine, lumefantrine and, to a lesser degree artesunate, which is consistent with previous studies [20-22].”
ResultSelf-citationFerreira, I. D., do Rosário, V. E., & Cravo, P. V. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-1 · Cited by 250 · cited 1×
“The efficiency of the pfmdr1 was back calculated using CT's for 3D7 and Dd2 in the previous formula [17,18].”
MethodALKER, A. P., LIM, P., SEM, R., SHAH, N. K., YI, P., BOUTH, D. M., TSUYUOKA, R., MAGUIRE, J. D., FANDEUR, T., ARIEY, F., et al. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.76.641 · Cited by 196 · cited 6×
“The association between pfmdr1 copy number and treatment failure to mefloquine-based regimens has been consistently found in both Cambodia and Thailand [5-7].”
BackgroundMethodInfluentialSelf-citationDenis, M. B., Tsuyuoka, R., Lim, P., Lindegardh, N., Yi, P., Top, S. N., Socheat, D., Fandeur, T., Annerberg, A., Christophel, E. M., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01739.x · Cited by 148 · cited 5×
“artemether-lumefantrine between October 2003 and March 2004 (AL2003, N = 80) [8] and 3.”
BackgroundMethodInfluentialSelf-citationDenis, M. B., Tsuyuoka, R., Poravuth, Y., Narann, T. S., Seila, S., Lim, C., Incardona, S., Lim, P., Sem, R., Socheat, D., et al. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01690.x · Cited by 138
Self-citationDurrand, V., Berry, A., Sem, R., Glaziou, P., Beaudou, J., & Fandeur, T. (2004) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2004.03.016 · Cited by 114 · cited 1×
“The number of variants in three polymorphic genes (msp1, msp2 and glurp) was determined as described previously [13,14].”
BackgroundSelf-citationPlasmodium Falciparum Resistant to Chloroquine in Cambodia
Eyles, D. E., Hoo, C. C., Warren, M., et al. (1963) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1963.12.840 · Cited by 64 · cited 1×
“Background Since the report of chloroquine resistance along the ThaiCambodian border in the late 1950s [1], Southeast Asia has been an important focus for the emergence and spread of drug resistance in Plasmodium falciparum.”
BackgroundKhim, N., Bouchier, C., Ekala, M. T., Incardona, S., Lim, P., Legrand, E., Jambou, R., Socheat, D., Mercereau‐Puijalon, O., & Fandeur, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3147-3152.2005 · Cited by 61 · cited 1×
“Sequencing reactions were performed from both ends using ABI Prism BigDye Terminator Cycle Sequencing-Ready Reaction kits, and were run on a 3700 Genetic Analyzer (Applied Biosystems) as described previously [15].”
MethodSelf-citationUhlemann, A., McGready, R. M., Ashley, E. A., Brockman, A., Singhasivanon, P., Krishna, S., White, N. J., Nosten, F. H., & Price, R. N. (2006) · The Journal of Infectious Diseases · doi:10.1086/509809 · Cited by 55 · cited 2×
“Interestingly, pfmdr1 copy number had apparently no impact on clinical AL failure even though it was associated with decreased in vitro susceptibility to both artemether and lumefantrine [19,22].”
BackgroundLim, P., Chim, P., Sem, R., Nemh, S., Yi, P., Lim, C., Seila, S., Tsuyuoka, R., Denis, M. B., Socheat, D., et al. (2004) · Acta Tropica · doi:10.1016/j.actatropica.2004.09.002 · Cited by 37 · cited 2×
“laboratory, or prolonged storage of infected blood at 4°C or presence of drug trace in the sample may have similarly interfere with the performance of the test [4].”
BackgroundSelf-citation
Cited by
Discovery, mechanisms of action and combination therapy of artemisinin
Cui, L., & Su, X.-Z. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.68 · Cited by 371
Venkatesan, M., Gadalla, N. B., Stepniewska, K., Dahal, P., Nsanzabana, C., Moriera, C., Price, R. N., Mårtensson, A., Rosenthal, P. J., Dorsey, G., et al. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0031 · Cited by 285
Self-citationDrug-Resistant Malaria: The Era of ACT
Lin, J. T., Juliano, J. J., & Wongsrichanalai, C. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0099-y · Cited by 121
Self-citation
Metadata
- Authors
- Lim, P., Alker, A. P., Khim, N., Shah, N. K., Incardona, S., Doung, S., Yi, P., Bouth, D. M., Bouchier, C., Puijalon, O. M., Meshnick, S. R., Wongsrichanalai, C., Fandeur, T., Le Bras, J., Ringwald, P., & Ariey, F.
- Venue
- Malaria Journal
- Published
- 2009-01-12
- Volume
- 8
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2048404226
- Cited by
- 179
- References
- 17
- FWCI
- 22.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.